Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Requena-Ibáñez, Juan Antonio
148  Ergebnisse:
Personensuche X
?
1

Inhibición dual del SGLT1 y SGLT2: algo más que su suma:

Sánchez-Muñoz, Enrique ; Requena-Ibáñez, Juan Antonio ; Badimón, Juan José
Revista Española de Cardiología.  77 (2024)  7 - p. 510-514 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Dual SGLT1 and SGLT2 inhibition: more than the sum of its p..:

Sánchez-Muñoz, Enrique ; Requena-Ibáñez, Juan Antonio ; Badimón, Juan José
Revista Española de Cardiología (English Edition).  77 (2024)  7 - p. 510-514 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): S..:

Pérez, Maeve Soto ; Rodríguez-Capitán, Jorge ; Requena-Ibáñez, Juan Antonio...
Cardiovascular Drugs and Therapy.  , 2023
Link: https://doi.org/10.1007/..
 
?
4

Empagliflozin effects on iron metabolism as a possible mech..:

Angermann, Christiane E. ; Santos-Gallego, Carlos G. ; Requena-Ibanez, Juan Antonio...
Nature Cardiovascular Research.  2 (2023)  11 - p. 1032-1043 , 2023
Link: https://doi.org/10.1038/..
 
?
5

Uncovering the Role of Epicardial Adipose Tissue in Heart F..:

Goldman, Sarah A. ; Requena-Ibanez, Juan Antonio ; Devesa, Ana...
JACC: Advances.  2 (2023)  9 - p. 100657 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Empagliflozin improves quality of life in nondiabetic HFrEF..:

Requena-Ibáñez, Juan Antonio ; Santos-Gallego, Carlos García ; Rodriguez-Cordero, Anderly..
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.  16 (2022)  2 - p. 102417 , 2022
Link: https://doi.org/10.1016/..
 
?
7

High-density lipoprotein cholesterol: a new marker in heart..:

Santos-Gallego, Carlos G. ; Requena-Ibáñez, Juan Antonio ; Badimón, Juan José
Revista Española de Cardiología (English Edition).  75 (2022)  11 - p. 855-857 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Not only how much, but also how to, when measuring epicardi..:

Requena-Ibáñez, Juan Antonio ; Santos-Gallego, Carlos García ; Rodriguez Cordero, Anderly José...
Magnetic Resonance Imaging.  86 (2022)  - p. 149-151 , 2022
Link: https://doi.org/10.1016/..
 
?
9

SGLT2-Inhibitors on HFpEF Patients. Role of Ejection Fracti..:

Requena-Ibanez, Juan Antonio ; Santos-Gallego, Carlos G. ; Zafar, M. Urooj.
Cardiovascular Drugs and Therapy.  37 (2022)  5 - p. 989-996 , 2022
Link: https://doi.org/10.1007/..
 
?
10

SGLT2i in heart failure: can their benefits be expanded acr..:

Requena-Ibáñez, Juan Antonio ; Santos-Gallego, Carlos G. ; Badimón, Juan José
Revista Española de Cardiología (English Edition).  75 (2022)  10 - p. 833-841 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal a..:

Requena-Ibáñez, Juan Antonio ; Santos-Gallego, Carlos G. ; Rodriguez-Cordero, Anderly..
Cardiovascular Drugs and Therapy.  36 (2021)  6 - p. 1187-1196 , 2021
Link: https://doi.org/10.1007/..
 
?
12

Clinical Prognosis Associated With the Use of Overlapping S..:

Abellán-Huerta, José ; Jurado-Román, Alfonso ; Lozano-Ruiz-Poveda, Fernando...
Cardiovascular Revascularization Medicine.  21 (2020)  11 - p. 1355-1359 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Are the antidiabetic SGLT2 inhibitors a cardiovascular trea..:

Vargas Delgado, Ariana P. ; Requena Ibañez, Juan Antonio ; Santos-Gallego, Carlos G..
Clínica e Investigación en Arteriosclerosis (English Edition).  33 (2021)  1 - p. 33-40 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Taquicardia ventricular polimórfica y miocardio no compacta..:

Pérez Díaz, Pedro ; Jurado Román, Alfonso ; Moreno Reig, Álvaro...
Revista Colombiana de Cardiología.  27 (2020)  6 - p. 583-587 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Congenital Septal Aneurysm and Embolic Myocardial Infarctio:

Requena Ibáñez, Juan Antonio ; López Lluva, María Thiscal ; Arizón Muñoz, José María
Revista Española de Cardiología (English Edition).  71 (2018)  9 - p. 751 , 2018
Link: https://doi.org/10.1016/..
 
1-15